BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...general counsel. She was EVP of patient access and corporate development and general counsel at Rosetta Genomics Ltd....
BioCentury | Dec 1, 2016
Financial News

Rosetta Genomics completes direct public offering and private placement

...Aegis Capital and Maxim Group are placement agents for the offerings. Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Alex Himes Rosetta Genomics Ltd....
BioCentury | Nov 2, 2015
Clinical News

RosettaGX Reveal: Clinical trial data

...International Thyroid Congress and Annual Meeting of the American Thyroid Association in Lake Buena Vista. Rosetta Genomics Ltd....
BioCentury | Oct 26, 2015
Company News

Rosetta Genomics sales and marketing update

...Rosetta launched a BRAF mutation analysis test for use in melanoma and colon cancer. Rosetta Genomics Ltd. (NASDAQ:ROSG...
BioCentury | Oct 19, 2015
Financial News

Rosetta Genomics completes private placement of units

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Date completed: 2015-10-14 Type: Private placement of units Raised: $8 million Units: 3.3 million Price: $2.40 (unit) Shares after offering: 17.8 million Placement agent: Aegis Capital Investor:...
BioCentury | Jul 13, 2015
Company News

Rosetta Genomics sales and marketing update

...outcomes at the initial diagnosis of bladder cancer. The company did not respond to inquiries. Rosetta Genomics Ltd....
BioCentury | May 4, 2015
Company News

Rosetta Genomics, Admera Health sales and marketing update

...implicated in cancer and chemotherapy. Rosetta has rights to the test under a 2014 deal. Rosetta Genomics Ltd....
BioCentury | May 4, 2015
Company News

Prelude, Rosetta Genomics deal

...recorded revenues of $6.9 million in the same period. Prelude Corp. , Laguna Hills, Calif. Rosetta Genomics Ltd....
BioCentury | Mar 9, 2015
Company News

Precipio, Rosetta Genomics deal

...malignancies. The companies did not respond to inquiries. Precipio Diagnostics LLC , New Haven, Conn. Rosetta Genomics Ltd....
BioCentury | Sep 1, 2014
Company News

Rosetta Genomics management update

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Hired: Douglas Sites as EVP of sales and marketing, a newly created position, formerly VP of sales and marketing at Asuragen Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 135
BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...general counsel. She was EVP of patient access and corporate development and general counsel at Rosetta Genomics Ltd....
BioCentury | Dec 1, 2016
Financial News

Rosetta Genomics completes direct public offering and private placement

...Aegis Capital and Maxim Group are placement agents for the offerings. Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Alex Himes Rosetta Genomics Ltd....
BioCentury | Nov 2, 2015
Clinical News

RosettaGX Reveal: Clinical trial data

...International Thyroid Congress and Annual Meeting of the American Thyroid Association in Lake Buena Vista. Rosetta Genomics Ltd....
BioCentury | Oct 26, 2015
Company News

Rosetta Genomics sales and marketing update

...Rosetta launched a BRAF mutation analysis test for use in melanoma and colon cancer. Rosetta Genomics Ltd. (NASDAQ:ROSG...
BioCentury | Oct 19, 2015
Financial News

Rosetta Genomics completes private placement of units

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Date completed: 2015-10-14 Type: Private placement of units Raised: $8 million Units: 3.3 million Price: $2.40 (unit) Shares after offering: 17.8 million Placement agent: Aegis Capital Investor:...
BioCentury | Jul 13, 2015
Company News

Rosetta Genomics sales and marketing update

...outcomes at the initial diagnosis of bladder cancer. The company did not respond to inquiries. Rosetta Genomics Ltd....
BioCentury | May 4, 2015
Company News

Rosetta Genomics, Admera Health sales and marketing update

...implicated in cancer and chemotherapy. Rosetta has rights to the test under a 2014 deal. Rosetta Genomics Ltd....
BioCentury | May 4, 2015
Company News

Prelude, Rosetta Genomics deal

...recorded revenues of $6.9 million in the same period. Prelude Corp. , Laguna Hills, Calif. Rosetta Genomics Ltd....
BioCentury | Mar 9, 2015
Company News

Precipio, Rosetta Genomics deal

...malignancies. The companies did not respond to inquiries. Precipio Diagnostics LLC , New Haven, Conn. Rosetta Genomics Ltd....
BioCentury | Sep 1, 2014
Company News

Rosetta Genomics management update

Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Hired: Douglas Sites as EVP of sales and marketing, a newly created position, formerly VP of sales and marketing at Asuragen Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 135